Skip to main content

Table 3 Comparisons of quality of life and symptoms between the different medical care of patients: Results from questionnaires

From: Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study

Score

Active surveillance

Radical prostatectomy

Radiotherapy or Brachytherapy or HIFU or ADT

Combined care

p-value

QLQ-C30

 Summary score QLQ-C30

97.44 [94.83; 100]

95.51 [87.65; 98.72]

92.31 [87.44; 97.78]

93.25 [84.44; 98.72]

0.0192

 Global health status/QOL: Poorer global health (<=83.3), n (%)

6 (15.4)

58 (31.2)

18 (34)

35 (38.9)

0.0694

 Physical Functioning: score < 100, n (%)

10 (25.6)

60 (32.3)

27 (50.9)

36 (40.5)

0.0319

 Role Functioning: score < 100, n (%)

5 (12.8)

37 (19.9)

11 (20.8)

17 (19.1)

0.76

 Emotional Functioning: score < 100, n (%)

18 (46.2)

102 (54.8)

28 (52.8)

53 (58.9)

0.60

 Cognitive Functioning: score < 100, n (%)

11 (28.2)

79 (42.7)

27 (50.9)

51 (56.7)

0.0153

 Social Functioning: score < 100, n (%)

5 (12.8)

46 (24.7)

12 (22.6)

28 (31.1)

0.1671

 Fatigue: score > 0, n (%)

12 (30.8)

88 (47.3)

28 (52.8)

38 (42.2)

0.1589

 Nausea/Vomiting: score > 0, n (%)

1 (2.6)

5 (2.7)

2 (3.8)

8 (8.9)

0.1320*

 Pain: score > 0, n (%)

9 (23.1)

42 (22.6)

12 (22.6)

23 (25.6)

0.96

 Dyspnea: score > 0, n (%)

6 (15.4)

37 (20)

17 (32.1)

22 (24.7)

0.1834

 Insomnia: score > 0, n (%)

10 (25.6)

60 (32.3)

20 (37.7)

36 (40)

0.36

 Appetite loss: score > 0, n (%)

1 (2.6)

10 (5.4)

2 (3.9)

6 (6.7)

0.88*

 Constipation: score > 0, n (%)

1 (2.6)

38 (20.5)

9 (17)

17 (18.9)

0.0640

 Diarrhea: score > 0, n (%)

7 (18)

23 (12.5)

11 (21.2)

12 (13.3)

0.40

 Financial Problems: score > 0, n (%)

2 (5.3)

11 (6)

2 (3.9)

7 (8.1)

0.80*

IPSS

 Mild

23 (63.9)

137 (76.5)

28 (60.9)

63 (75)

 

 Moderate

9 (25)

37 (20.7)

13 (28.3)

15 (17.9)

0.0730

 Severe

4 (11.1)

5 (2.8)

5 (10.9)

6 (7.1)

 

ICIQ-MLUTS

 Voiding score (VS)

4 [1; 7]

2 [0; 4]

3.5 [2; 6]

3 [1; 5]

0.0011

 Incontinence score (IS)

3 [0; 4]

4 [2; 6]

2 [1;4]

2 [1.5; 6]

< 0.0001

 Frequency of diurnal urination

  - 1–6 times per day

22 (56.4)

106 (59.2)

30 (55.6)

51 (58.6)

 

  - 7–8 times per day

13 (33.3)

50 (27.9)

17 (31.5)

26 (29.9)

0.99

  - ≥9 times per day

4 (10.3)

23 (12.9)

7 (13)

10 (11.5)

 

 Frequency of nocturnal urination

  - Never

7 (18)

44 (24.3)

8 (15.1)

15 (16.9)

 

  - 1 time per night

19 (48.7)

89 (49.2)

23 (43.4)

55 (61.8)

0.0925

  - ≥ 2 times per night

13 (33.3)

48 (26.5)

22 (41.5)

19 (21.4)

 

IIEF-6

 No dysfunction

9 (23.1)

11 (5.9)

5 (9.3)

9 (10)

 

 Mild, Mild to moderate, or Moderate dysfunction

17 (43.6)

25 (13.4)

14 (25.9)

16 (17.8)

< 0.0001

 Severe Erectile dysfunction

13 (33.3)

151 (80.8)

35 (64.8)

65 (72.2)

 

HADS

 HADS anxiety

  - Absence of anxiety

31 (81.6)

124 (71.3)

42 (82.4)

64 (74.4)

 

  - Suspected anxiety

6 (15.8)

32 (18.4)

7 (13.7)

13 (15.1)

0.49

  - Probable anxiety

1 (2.6)

18 (10.3)

2 (3.9)

9 (10.5)

 

 HADS depression

  - Absence of anxiety

33 (86.8)

145 (81.5)

44 (89.8)

75 (88.2)

 

  - Suspected anxiety

5 (13.2)

19 (10.7)

3 (6.1)

9 (10.6)

0.1588

  - Probable anxiety

0

14 (7.9)

2 (4.1)

1 (1.2)

 

 HADS Total score

  - Absence of anxio-depressive troubles

33 (86.8)

130 (76.9)

40 (85.1)

69 (83.1)

0.34

  - Presence of anxio-depressive troubles

5 (13.2)

39 (23.1)

7 (14.9)

14 (16.9)

 
  1. Data presented as number (%) or median [IQR] as appropriate. * Fisher test; Khi2 test otherwise